Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.
about
Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverPrimary sclerosing cholangitis: diagnosis and treatmentThe indications for liver biopsyPrimary sclerosing cholangitis: diagnosis, prognosis, and management.Prevention of infection caused by immunosuppressive drugs in gastroenterology.High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.Evolving concepts in primary sclerosing cholangitis.The overlap syndromes of autoimmune hepatitis.Overlap syndromes of autoimmune hepatitis: an open question.Role of endoscopy in the diagnosis of autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis.Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.Primary sclerosing cholangitis: a clinical update.Overlap syndrome consisting of PSC-AIH with concomitant presence of a membranous glomerulonephritis and ulcerative colitis.Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
P2860
Q26766699-4D7BD81A-FF09-4F98-92B2-12547E8A4C76Q26829216-F4F57C8D-CA7C-4C21-BA5D-2D83E7D7EAB3Q27021099-BA7E667B-A26C-4738-96C0-DEABA8A25BE0Q36955053-3AC2BC4D-F845-4326-B2B9-89ACA52DC578Q36971789-2972D190-AFF9-4DBB-AD5A-4742B28BB55AQ37117971-4E7DBB0A-9DF1-4B3D-87BA-10BAA06AABFEQ37317444-677A087D-96B6-4C50-BA33-57E47EF8C5A8Q37957967-0BA4B5E6-CBE7-411A-B144-AEA179B432B2Q38037392-02BAFA30-4A6E-4CDD-8454-BF0261F99823Q38053908-B5341C4B-2B0F-4322-8746-6C9FB0D4F969Q38202999-4D862054-A1D0-47D4-83A5-ED57FBD0BDFAQ38412069-EDAE96F5-44E4-42F5-9092-BFD49F4CA2E6Q38485235-9EAF7E92-EACE-4714-9114-0063DD907764Q38979887-13BE279B-FD33-4C87-A62A-E76633D9AE79Q40989271-F431A43C-BEF0-4A02-B0ED-223C3C6F0280Q42375565-CBE4A1D5-3625-4C5E-B103-986246463BC4Q45151761-CEE4BB7E-5F7B-4C53-B18B-BECDBFF5B157Q55114620-748EEBC2-BDC1-4B7A-ABDB-0325EBFC141B
P2860
Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review: management ...... lap with autoimmune hepatitis.
@en
Systematic review: management ...... lap with autoimmune hepatitis.
@nl
type
label
Systematic review: management ...... lap with autoimmune hepatitis.
@en
Systematic review: management ...... lap with autoimmune hepatitis.
@nl
prefLabel
Systematic review: management ...... lap with autoimmune hepatitis.
@en
Systematic review: management ...... lap with autoimmune hepatitis.
@nl
P2860
P1476
Systematic review: management ...... lap with autoimmune hepatitis.
@en
P2093
R W Chapman
P2860
P304
P356
10.1111/J.1365-2036.2011.04658.X
P407
P577
2011-04-18T00:00:00Z